No Data
No Data
William Blair Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating
Strategic Growth and Financial Positioning: Arcturus Therapeutics' Promising Outlook Amid Upcoming Trial Data and Financial Adjustments
Despite Revenue Setback, Arcturus Therapeutics (ARCT) Vaccine Breakthroughs Fuel Optimism
Arcturus Therapeutics Is Maintained at Buy by Canaccord Genuity
CCORF Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Cuts Target Price to $68
BTIG Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $48
sooogod : How does this company have such a small Trade volume?
10baggerbamm OP sooogod : Bill Gates is backing this company. today's volume is extremely light I don't have an answer for it you see it it stands out like a sore thumb today there's just no buyers.. maybe they're waiting for like a $15.70 print 15.50 print I don't know but what I do know is out of nowhere is it reverses